One possible strategy could involve first restoring the susceptibility of autoreactive T cells to Treg-mediated suppression using DMD, followed by expanding and enhancing Treg function through CD4-mediated activation to strengthen regulatory control [52]. This evidence concerns the gene CD4 and Duchenne muscular dystrophy.